Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Successful treatment of postoperative multidrug-resistant Acinetobacter baumannii meningitis by tigecycline
Ikbel Kooli1, Hajer Ben Brahim1, Mohamed Kilani2
1Department of Infectious Diseases, Fattouma Bourguiba Hospital, Farhat Hached Street 5000, Monastir, Tunisia.
Abstract:
Tigecycline is a broad-spectrum antibiotic with activity against multidrug-resistant (MDR) bacteria. It has limited indications. Studies are necessary to elaborate new guidelines. Here we report a case of postoperative MDR Acinetobacter baumannii meningitis treated by tigecycline combined with colimycin for 21 days. The treatment was well tolerated with a favourable outcome. In conclusion, tigecycline was shown to be effective in a case of MDR A. baumannii meningitis.